Braxia Scientific Overview
Latest ROE for Braxia Scientific: 2635.03% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow2635.03%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, BRAXF shows a ROE of 2635.03%. That is above the Healthcare sector average of 11.15%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 11.15%. Braxia Scientific is at 2635.03%, which is higher that average. That is roughly 23524.0% above the sector mean. Use the comparison chart on this page to see how BRAXF stacks up against individual peers as well.
Check the historical chart to see whether BRAXF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Braxia Scientific with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Braxia Scientific's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 2635.03%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 11.15%, while BRAXF is at 2635.03%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
